Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Iliac Branch System Helps Control Aneurysms

By HospiMedica International staff writers
Posted on 15 Mar 2016
A novel all-in-one system helps preserve iliac artery blood flow in patients with common iliac artery aneurysms or aortoiliac aneurysms.

The Gore Excluder Iliac Branch Endoprosthesis (IBE) is a complete, fully engineered system that includes iliac branch and internal iliac components. More...
The device is intended for use in conjunction with the Gore Excluder AAA Endoprosthesis to isolate the common iliac artery from systemic blood flow, and preserve blood flow in the external iliac and internal iliac arteries. The device is made of durable expanded polytetrafluoroethylene (ePTFE) graft material and a nitinol stent, similar to the AAA Endoprosthesis.

The IBE device offers a wide internal iliac artery treatment range of 6.5 to 13.5 mm, and is repositionable to precisely place the iliac component. It is installed using a delivery catheter and 16 French introducer sheath in the case of the iliac branch component, and a 12 French introducer sheath in the case of the internal iliac component. The Gore Excluder IBE is a product of Gore Medical Products (Flagstaff, AZ, USA), and has been approved by the US Food and Drug Administration (FDA).

“The Gore Excluder iliac branch device has demonstrated high patency, conformability, and durability, and provides physicians with an on-label, minimally invasive method of preserving flow to the internal and external iliac arteries,” said Ryan Takeuchi, aortic business leader at Gore Medical Products (Flagstaff, AZ, USA). “Not only is IBE the first off-the-shelf aortic branch device approved in the United States, it is a part of a complete portfolio of aortic branch solutions that are currently in clinical evaluation.”

“Historically, options to preserve flow to the internal iliac arteries during endovascular aneurysm repair were very limited, despite the involvement of the iliac arteries in about 25% of AAA cases,” said Darren Schneider, MD, chief of vascular and endovascular surgery at Weill Cornell Medical College (New York, NY, USA). “Through our research and the subsequent FDA approval, physicians now have a new therapeutic option to preserve pelvic perfusion in order to improve clinical outcomes and maintain patient quality of life.”

Preservation of blood flow in the internal iliac arteries avoids pelvic flow disruption and reduces the rate of buttock claudication, sexual dysfunction, and colonic ischemia.

Related Links:

Gore Medical Products
Weill Cornell Medical College



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.